| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 120.0 | 116.2 | 99.8 |
| Other income | 1.6 | 2.8 | 0.1 |
| Total income | 121.6 | 119.0 | 99.9 |
| Profit before exceptional items & tax | 21.2 | 23.4 | 18.6 |
| Profit before tax | 21.2 | 23.4 | 18.6 |
| Net profit | 16.2 | 17.3 | 16.0 |
| Operating margin | 17.4% | 19.7% | 18.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +1.20% |
|---|---|
| Net profit, quarter on quarter | -6.40% |
| Revenue, year on year | +20.20% |
BSE results filing, NSE: DRAGARWQ. Figures extracted from the filing.
Dr. Agarwal's Eye Hospital Ltd: key numbers
- Share price
- ₹5,155.20
- Market cap
- ₹2,423 Cr
- Revenue (annual)
- ₹470.9 Cr
- Net profit (annual)
- ₹70.10 Cr
- P/E (TTM)
- 31.8×Sector 53.1×
- Promoter holding
- 72.67%+0.00% QoQ
- FII holding
- 2.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwal's Eye Hospital Ltd
All →Dr. Agarwal's Eye Hospital Annual General Meeting
Dr. Agarwal's Eye Hospital Limited held its 32nd Annual General Meeting on September 09, 2026. The meeting concluded with the approval of six business resolutions.
Dr. Agarwal's Eye Hospital Business Update
Dr. Agarwals Eye Hospital inaugurated its new Pinhole Pupilloplasty Centre in Chennai. This facility provides advanced specialized clinical treatments for patients with complex corneal conditions.
Dr. Agarwal's Eye Hospital Annual General Meeting
Dr. Agarwal’s Eye Hospital will hold its 32nd Annual General Meeting on September 09, 2026. The meeting includes approval for a final dividend of ₹4.00 per share.
Dr. Agarwal's Eye Hospital Annual Report
Dr. Agarwal's Eye Hospital Limited has submitted its Annual Report for the financial year 2025-26, including the notice for its 32nd Annual General Meeting.
Dr. Agarwal's Eye Hospital Capital Structure Change
Invesco Mutual Fund acquired a 2.1885% stake in Dr. Agarwal's Healthcare Limited via open market. Its total holding in the company now stands at 5.2125%.
Dr. Agarwal's Eye Hospital Other Announcement
Dr. Agarwal's Eye Hospital Limited has re-appointed M/s. B Y & Associates as Cost Auditor for a one-year term.
- Execution
- 12 months